Bayer's $7.25B Roundup Settlement Faces Missouri Court Test

Bayer is preparing for a significant legal moment as a Missouri court reviews its $7.25 billion settlement involving Roundup claims. The proceeding is expected to serve as a pivotal test of the agreement, which is meant to resolve a broad set of disputes tied to the weedkiller.

The outcome in Missouri matters because the settlement's structure and final approval could influence how similar claims move through the courts. Bayer has long faced litigation over Roundup, and the company has sought a lasting resolution. Investors and claimants will be watching whether the court accepts the deal as presented or requires changes.

Settlement approvals can be unpredictable. Courts weigh whether terms are fair and whether they adequately address the interests of those covered. A rejection or revision could prolong uncertainty for Bayer, while an approval could provide a clearer path forward. The Missouri hearing is therefore likely to draw close attention from both sides.

The case reflects broader pressure on Bayer over Roundup, which has generated years of litigation and settlement talks. How the Missouri court handles the $7.25 billion package may shape expectations for remaining disputes and future negotiations. For now, the company faces a high-stakes review that could define the next phase of the matter.